清热调血汤内服联合五味消毒饮灌肠治疗湿热瘀滞证盆腔炎性疾病后遗症的临床观察

胡春芳; 简皓; 陈姣洁; 熊员焕

doi:10.13422/j.cnki.syfjx.20200734

您当前的位置：

首页 >

文章列表页 >

清热调血汤内服联合五味消毒饮灌肠治疗湿热瘀滞证盆腔炎性疾病后遗症的临床观察

临床 | 更新时间：2020-09-16

- 清热调血汤内服联合五味消毒饮灌肠治疗湿热瘀滞证盆腔炎性疾病后遗症的临床观察
- Clinical Observation of Qingre Tiaoxue Decoction Combined with Wuwei Xiaodu Drink in Enema Treatment of Sequelae of Pelvic Inflammatory Disease
- 中国实验方剂学杂志 2020年26卷第20期页码：111-116
- 作者机构：
  
  1.新余市妇幼保健院，江西新余 338025
  2.江西省中医院，南昌 330004
  3.江西省人民医院，南昌 330012
- 作者简介：
  
  胡春芳，硕士，副主任医师，从事产科急症重症和高危妊娠的诊治工作，E-mail：1305792543@qq.com
  熊员焕，博士，主任医师，从事妇产科临床工作，E-mail：xiongyuanhuan@163.com
- 基金信息：
  
  江西省卫生计生委中医药科研项目(2017B051)
- DOI：10.13422/j.cnki.syfjx.20200734
  中图分类号： R289;R71;R711;R711.3
- 收稿日期：2020-03-27，
  
  网络出版日期：2020-05-08，
  
  纸质出版日期：2020-10-20
- 稿件说明：
移动端阅览
胡春芳,简皓,陈姣洁等.清热调血汤内服联合五味消毒饮灌肠治疗湿热瘀滞证盆腔炎性疾病后遗症的临床观察[J].中国实验方剂学杂志,2020,26(20):111-116.

HU Chun-fang,JIAN Hao,CHEN Jiao-jie,et al.Clinical Observation of Qingre Tiaoxue Decoction Combined with Wuwei Xiaodu Drink in Enema Treatment of Sequelae of Pelvic Inflammatory Disease[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(20):111-116.
胡春芳,简皓,陈姣洁等.清热调血汤内服联合五味消毒饮灌肠治疗湿热瘀滞证盆腔炎性疾病后遗症的临床观察[J].中国实验方剂学杂志,2020,26(20):111-116. DOI： 10.13422/j.cnki.syfjx.20200734.

HU Chun-fang,JIAN Hao,CHEN Jiao-jie,et al.Clinical Observation of Qingre Tiaoxue Decoction Combined with Wuwei Xiaodu Drink in Enema Treatment of Sequelae of Pelvic Inflammatory Disease[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(20):111-116. DOI： 10.13422/j.cnki.syfjx.20200734.

摘要

目的

清热调血汤内服联合五味消毒饮灌肠评价中医综合疗法治疗盆腔炎性疾病后遗症（湿热瘀滞证）的临床疗效及对免疫炎症因子的调节作用。

方法

将160例患者按随机数字表法以1∶1分为观察组和对照组各80例。对照组脱落、失访4例，剔除3例，完成73例；观察组脱落、失访4例，剔除2例，完成74例。对照组口服妇科千金胶囊，2粒/次，3次/d；采用五味消毒饮加减灌肠，1剂/d，煎制剂成150 mL，保留灌肠，1次/晚，保留2～4 h，于月经后3 d开始灌肠，每个周期连续灌肠14 d。观察组灌肠治疗同对照组，并给予清热调血汤加减内服，1剂/d。连续治疗3个月经周期，经期停服。盆腔疼痛程度采用疼痛视觉模拟评分（VAS）法，分别评价痛经程度和非经期下腹、腰骶的疼痛程度；进行治疗前后湿热瘀滞证，Mc Cormack量表，世界卫生组织生存质量测定简表（WHOQOL-BREF）评分；进行治疗前后阴道彩超检查、宫颈分泌物培养和白带常规检查；检测治疗前后CD4

，CD8

，CD4

/CD8

等T淋巴细胞亚群和肿瘤坏死因子（TNF）-

，白细胞介素-2 (IL-2)，IL-6水平；并进行安全性评价。

结果

经重复测量的方差分析，两组患者治疗后痛经VAS评分和非经期VAS评分均逐渐下降（

0.05），观察组在3个月经周期期间和治疗后的痛经VAS评分和非经期VAS评分均低于对照组（

0.01）；观察组体征评分、湿热瘀滞证评分均低于对照组（

0.01），WHOQOL-BREF评分高于对照组（

0.01）；观察组患者盆腔积液深度和盆腔炎性包块的体积均小于对照组（

0.01）；观察组CD4

和CD4

/CD8

高于对照组（

0.01），CD8

低于对照组（

0.01）；观察组TNF-

和IL-6水平均低于对照组（

0.01），IL-2水平高于对照组（

0.01）；观察组综合疗效优于对照组（

＝2.028，

0.05）；观察组中医证候疗效优于对照组（

＝2.064，

0.05）；研究过程患者均没有发生严重不良事件，未发现中药相关不良反应。

结论

清热调血汤加减内服联合五味消毒饮加减灌肠的综合疗法干预SPID湿热瘀滞证患者，可明显改善临床症状和体征，提高患者生活质量，并能调节细胞免疫功能和炎症因子，有着较好的综合疗效和中医证候疗效，临床使用安全。

Abstract

Objective

To discuss clinical effect of comprehensive Qingre Tiaoxue decoction combined with Wuwei Xiaodu drink and enema to sequelae of pelvic inflammatory disease (syndrome of dampness heat stasis) and to study the moderating effect to immune inflammatory factor.

Method

One hundred and sixty patients were randomly divided into control group (80 cases) and observation group (80 cases) by random number table. The 73 patients in control group completed the therapy (4 patients were exfoliated or lost to follow-up

3 patients were eliminate)

74 patients in observation group completed the therapy (4 patients were exfoliated or lost to follow-up

2 patients were eliminate). Patients in control group got Fuke Qianjin capsules

2 grains/time

3 times/day

and at the third day after menstruation

addition and subtraction therapy of Wuwei Xiaodu drink with enema for 14 days at every night

1 dose/day

and enema continued for 2-4 h/day. Based on the treatment of enema in control group

patients in observation group added Qingre Tiaoxue decoction for 3 menstrual cycles

1 dose/day

and stopping during menstrual cycle. Degree of pelvic pain

dysmenorrhea and the degree of pain in the lower abdomen and lumbosacral in the non menstrual period were evaluated by pain visual simulation score (VAS). Before and after treatment

scores of syndrome of dampness heat stasis

Mc Cormack scale

and Summary of the World Health Organization Quality of Life Measurement Scale (WHOQOL-BREF) scale were graded

and vaginal ultrasonography

culture of cervical secretion and routine examination of leucorrhea were detected. And levels of CD4

CD8

CD4

/CD8

T lymphocyte subsets

tumor necrosis factor-

(TNF-

)

interleukin-2 (IL-2) and IL-6 were detected and safety was evaluated.

Result

By ANOVA of repeated measurement

after treatment

scores of VAS during dysmenorrheal and VAS during non menstrual period in two groups decreased (

0.05)

and during 3 menstrual cycles

scores of VAS during dysmenorrheal and VAS during non menstrual period in observation group were lower than those in control group (

0.01). Scores of physical sign and syndrome of damp heat and stasis were lower than those in control group (

0.01)

score of WHOQOL-BREF was higher than that in control group (

0.01). The depth of pelvic effusion and the volume of pelvic inflammatory mass in observation group were less than those in control group (

0.01). Levels of CD4

CD4

/CD8

and IL-2 were higher than those in control group (

0.01)

and levels of CD8

TNF-

and IL-6 were lower than those in control group (

0.01). Comprehensive curative effect in observation group was better than that in control group (

=2.028

0.05). And curative effect of traditional Chinese medicine（TCM） Syndrome in observation group was better than that in in control group (

=2.064

0.05). And there were no serious adverse events and adverse reaction caused by Chinese medicine.

Conclusion

Comprehensive therapy of Chinese medicine and enema to sequelae of pelvic inflammatory disease can improve the clinical symptoms and signs

improve the quality of life of patients

and regulate the cellular immune function and inflammatory factors. It has better comprehensive curative effect and TCM syndrome curative effect

and is safe for clinical use.

关键词

Keywords

references

蒋南 , 姜頔 . 膈下逐瘀汤加减治疗盆腔炎性疾病后遗症-慢性盆腔痛临床研究 [J]. 中药新药与临床药理 , 2019 , 30 ( 8 ): 985 - 989 .

SUSS A L , HOMEL P , HAMMERSCHLAG M , et al . Risk factors for pelvic inflammatory disease in inner-city adolescents [J]. Sex Traosm Dis , 2000 ， 27 : 289 - 291 .

中华医学会妇产科学分会感染性疾病协作组 . 盆腔炎症性疾病诊治规范(2019修订版) [J]. 中华妇产科杂志 , 2019 , 54 ( 7 ): 433 - 437 .

杨丽 , 时燕萍 . 时燕萍治疗湿热瘀阻型盆腔炎性疾病后遗症经验 [J]. 长春中医药大学学报 , 2019 , 35 ( 6 ): 1065 - 1067 .

马堃 , 罗颂平 , 李敏 , 等 . 中医药防治盆腔炎性疾病优势与证据研究进展 [J]. 中国中药杂志 , 2017 , 42 ( 8 ): 1449 - 1454 .

胡春芳 , 简皓 , 毛连芬 . 五味消毒饮灌肠配合VLH-D仪治疗盆腔炎性疾病后遗症临床研究 [J]. 中国中医药现代远程教育 , 2019 , 17 ( 22 ): 117 - 119 .

钟高堂 . 清热调血汤配合消癥散外敷对湿热瘀结型慢性盆腔炎患者免疫功能的影响 [J]. 现代中西医结合杂志 , 2016 , 25 ( 14 ): 1533 - 1535 .

谢幸 , 苟文丽 . 妇产科学 [M]. 8 版 .北京 : 人民卫生出版社 , 2013 : 258 - 264 ．

中华中医药学会 . 中医妇科常见病诊疗指南 [M]. 北京 : 中国中医药出版社 , 2012 : 117 - 120 .

孙阿梅，刘长云，刘汉蓉，等 . 中药灌肠联合外体电场热疗对慢性盆腔炎患者炎性因子、免疫功能及血流变学的影响 [J]. 世界中医药 , 2018 , 13 ( 5 ): 1111 - 1114 .

陈聪 , 苏泽琦 , 彭莉 , 等 . 秦月好治疗盆腔炎性疾病后遗症经验 [J]. 中国中医药信息杂志 , 2018 , 25 ( 1 ): 111 - 113 .

王春环 , 李维民 , 刘秀云 , 等 . 中医外治法在慢性盆腔炎中的应用研究进展 [J]. 江苏中医药 , 2016 , 48 ( 2 ): 83 - 85 .

吴丹 , 陈晨 , 刘树民 , 等 . 从“正虚邪恋”理论探讨盆腔炎性疾病后遗症的发病特点 [J]. 中国医药导报 , 2019 , 16 ( 34 ): 138 - 140 .

STEVENB J S , CRISS A K . Pathogenesis of Neisseria gonorrhoeae in the female reproductive tract: neutrophilic host response, sustained infection, and clinical sequelae [J]. Curr Opin Hematol , 2018 , 25 ( 1 ): 13 - 21 .

任存霞 , 高升 . 消炎一号方灌肠和口服治疗慢性盆腔炎疗效比较及免疫机制研究 [J]. 中药药理与临床 , 2015 , 31 ( 5 ): 126 - 128 .

RASMUSSEN C B , KJAER S K , ALBIERI V ， et al . Pelvic inflammatory disease and the risk of ovarian cancer and borderline ovarian tumors: a pooled analysis of 13 gase-control studies [J]. Am J Epidemiol , 2017 , 185 ( 1 ): 8 - 20 .

SHIGEMI D , MATSUI H , FUSHIMI K , et al . Laparoscopic compared with open surgery for severe pelvic inflammatory disease and tubo-ovarian abscess [J]. Obstet Gynecol , 2019 , 133 ( 6 ): 1224 - 1230 .

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

知柏地黄丸加减治疗小儿紫癜性肾炎肝肾阴虚证的疗效观察

参苓白术散加减辅助治疗卒中相关性肺炎肺脾气虚证的临床观察

参苓白术散加减治疗脾虚湿蕴型亚急性湿疹临床疗效及对炎症因子和外周血T淋巴细胞亚群的影响

瓜蒌红花甘草汤对肝经郁热型带状疱疹患者炎症因子和T淋巴细胞亚群的影响

银蒲四逆四妙失笑散加减辨治盆腔炎性疾病远期后遗症及对免疫-炎症因子的调节作用